Introduction
B acteria need to respond to changes in their environment. Therefore, they require adequate means to gain and process information on the immediate surroundings. Such means are represented by two-component systems (TCSs), which are ubiquitous in all prokaryotes. A typical TCS consists of a sensor histidine kinase (HK) and a response regulator (RR). 1 The HK measures a specific external signal and autophosphorylates at a conserved histidine residue within the cytosol. This phosphoryl group is transferred to the associated RR. The activated RR initiates the cellular response. 2 Most RRs are transcription factors that not only change the gene expression pattern of one or more genes of the cell, but also post-transcriptional and post-translational regulation of RNAs and proteins, respectively, by RRs has been reported. 3 The ability of bacteria to sense the signal enables them to react with an adaptive response.
Of special interest is the glycopeptide-sensing TCS VanRS that controls the expression of glycopeptide resistance genes in gram-positive pathogens, 4, 5 some glycopeptide producers, and other actinomycetes. 6 VanS is a membrane-standing HK. Its C-terminus extends into the cytoplasm and contains the kinase domain and the phosphorylation site. 7 VanS senses the presence of glycopeptides and catalyses adenosine triphosphate-dependent autophosphorylation of a specific histidine residue. Subsequently, VanS transfers the phosphate group to an aspartate residue of VanR, which then activates the transcription of the resistance genes. However, under noninduction conditions, VanS acts as a phosphatase, removing the phosphate group from VanR. 8 Glycopeptides such as vancomycin, teicoplanin, and telavancin are used for treating infections caused by gram-positive pathogens. They act by binding to the N-acyl-d-alanyl-dalanine (d-Ala-d-Ala) termini of peptidoglycan (PG) and its precursor lipid II. This binding effectively sequesters the substrate for the transglycosylases and the d,d-transpeptidases, two key enzymes of cell wall synthesis, resulting in an inability to grow and subsequently to cell death.
Glycopeptide resistance is mediated by reprogramming cell wall biosynthesis. Ten types of resistances have been characterized so far (VanA-N). 9, 10 In each case, the terminal . These substitutions result in a 1000-fold 11 or 6-fold 12 decreased binding affinity of the glycopeptide to its target, respectively. Categorization into the different phenotypes is based on the inducibility, the breadth of resistance to individual compounds, and the level of resistance. 9 Three of those phenotypes, VanC, 13 VanD, 14 and VanN, 15, 16 are constitutively expressed. All others are inducible to different degrees by different glycopeptides. It was shown that enterococcus and staphylococcus strains expressing glycopeptide resistance genes constitutively are impaired in growth in comparison with strains where the genes are inducible. 17, 18 Apparently, careful control of the expression of these genes is advantageous.
Streptomyces coelicolor A3 (2) is neither a pathogen nor a glycopeptide producer, but it is likely to encounter glycopeptides in its natural habitat. Therefore, it benefits from carrying vanRS Sc , vanHAX Sc , vanK Sc , and vanJ Sc (Fig. 1C) 19 VanY is a membrane protein conferring resistance to teicoplanin. To identify the precise nature of the ligand signal that activates glycopeptide resistance in S. coelicolor A3(2), the VanB-type HK VanS Sc , sensing vancomycin, but not teicoplanin, was investigated. 21, 22 Investigation on VanS Sc revealed opposed results. On the one hand, it was shown by cross-linking experiments that vancomycin is the direct ligand of the VanS Sc . 21 On the other hand, Kwun et al. 22 demonstrated that VanS Sc is activated by vancomycin in complex with the d-Ala-d-Ala termini of PG precursors. The actinomycete Amycolatopsis balhimycina produces the glycopeptide balhimycin, a vancomycin-type glycopeptide differing from vancomycin only in the glycosylation pattern. 23, 24 The balhimycin biosynthesis gene cluster contains all genes necessary for balhimycin production 25 as well the vanRS-like regulatory genes, vnlRS Ab and the accessory resistance gene vanY Ab (Fig. 1C) . 26 VanYAb is a carboxypeptidase which cleaves the endstanding D-Ala-DAla-dipeptide from the PG precursors. 27 However, the vanHAX Ab genes are encoded more than 2 Mb apart from the balhimycin biosynthesis cluster. Although VnlR Ab does not regulate glycopeptide resistance in A. balhimycina, 27 its heterologous expression in the glycopeptide-sensitive S. coelicolor strain M600 J2301 6 (DvanRS Sc ) revealed unexpected effects. VnlR Ab activates the vanHAX Sc genes, increases actinorhodin production, and influences morphological differentiation in S. coelicolor.
Materials and Methods

Bacterial, strains, plasmids, and primers
The strains and plasmids used for this study are listed in Table 1 , the primers used for this study are listed in Table 2 .
Escherichia coli XL1-blue 28 was used for cloning purposes, and the methylation-deficient strain E. coli ET12567 29 was used to obtain unmethylated DNA for A. balhimycina transformations. The site of aspartate phosphorylation is indicated by red and that of the proposed autophosphorylation by green arrow. (C) Organization of the resistance genes in Streptomyces coelicolor compared with that of Amycolatopsis balhimycina. ''-'' for a mismatch or a gap; ''.'' for any small positive score; '':'' for a similarity, which scores more than 1.0; and ''I'' for an identity where both sequences have the same residue.
A. balhimycina
24 is the balhimycin-producing wild type (WT) and was used to generate the vnlS deletion as well as the vnlR-overexpressing strains (this study). Furthermore, DvnlR deletion 27 was used for complementation (this study). S. coelicolor M600 30 were used to generate S. coelicolor M600 DvanRS. 6 This deletion strain was used to generate complementations with vnlRS Ab , vnlR Ab , vnlS Ab , and vnlR Ab-D51A (this study).
The overexpression plasmids pRM4vnlRS Ab , pRM4vnlR Ab , pRM4vnlS Ab , and pRM4vnlR Ab D51A are derived from pRM4 31 , a pSET152-derived nonreplicative, FC31 integration vector with an integrated constitutive ermEp* promoter, an artificial ribosomal binding site, and an apramycin resistance cassette.
The deletion vector pSPDvnlS Ab is derived from pSP1 32 in which flanking regions of vnlS Ab were cloned.
Media and culture conditions
A. balhimycina grown in 100 ml TSB medium (Difco) for 48 hr and 2 ml of this preculture were used to inoculate the main cultures either in 100 ml R5 30 or in TSB medium. R5 medium was used to stimulate balhimycin production, while TSB medium was used when balhimycin production should be prevented. After 48 hr of cultivation, the mycelium was used to isolate PG precursors, to extract DNA, or to perform resistance assays against different glycopeptides. To isolate RNA, the cells were grown 15/39/63 hr. Balhimycin production assays were performed after 5 days of growth.
S. coelicolor M145 and M600 were grown on Cullumagar plates for sporulation. Isolated spores were used to inoculate 10 ml R5 medium as preculture for cell wall precursor extraction or DNA extraction. For RNA isolation, 2 ml of a 48-hr-old TSB preculture was used to inoculate 100 ml of HA medium. The cells were harvested after 69 hr.
To compare the growth of the different S. coelicolor strains, 10 ml spores (*1.5 · 10 7 ) of each strain were streaked on a YM plate. The plate was incubated for 7 days.
A. balhimycina and S. coelicolor were grown at 30°C, and liquid cultures were shaken at 180 rpm.
A. balhimycina and S. coelicolor strains were cultivated in 100 ml of R5 medium in an orbital shaker (220 rpm) in 500-ml baffled Erlenmeyer flasks at 27°C.
Liquid/solid media were supplemented with 100 mg/ml apramycin to select for strains carrying integrated antibiotic resistance genes. 
E. coli was grown in Luria-Bertani broth (Roth) at 37°C using 100 mg/ml apramycin or 150 mg/ml ampicillin for selection of plasmid-containing colonies. Liquid cultures were shaken at 180 rpm.
Plasmid construction
For the heterologous expression in S. coelicolor DvanRS Sc , the entire coding regions of the vnlR Ab (Table 2 primer 1 + 3), vnlRS Ab (Table 2 primer 1 + 2), and vnlS Ab (primer 4 + 2) were amplified using Kapa-Hifi proofreading polymerase and the corresponding primers in brackets.
The vnlR Ab (758 bp), vnlRS Ab (1908 bp), and vnlS Ab (1198 bp) polymerase chain reaction (PCR) products were integrated into pRM4 31 through the primer-attached restriction sites (Nde-EcoRI) downstream of the ermEp* promoter.
Site-directed mutagenesis by overlap extension 33 was performed for the exchange of aspartate at position 51 to an alanine with the primers 5 + 6 ( Table 2 ). The 758 bp PCR product vnlR Ab D51A was integrated into pRM4 through the primer-attached restriction sites (Nde-EcoRI) downstream of the ermEp* promoter.
For the in-frame deletion of vnlS Ab (1125 bp), a 1579 bp upstream fragment (Table 2 primer 7 + 8) and a 1509 bp downstream fragment (Table 2 primer 9 + 10) of vnlS Ab were amplified from A. balhimycina genomic DNA using KapaHifi proofreading polymerase and the corresponding primers in brackets. The plasmid pSPDvnlS was constructed by integration of the fragments in pSP1 30 through the primerattached restriction sites at the 5¢ and 3¢ ends (EcoRI/XbaI and XbaI/SphI) (pSPDvnlS).
DNA transfer
Transformation of E. coli XL1-blue 28 and ET12567 (pUZ8002) 34 was performed as described previously. 35, 36 Plasmids pRM4vnlRS Ab , pRM4vnlR Ab , pRM4vnlS Ab , and pRM4vnlR Ab D51A were transferred into S. coelicolor through intergeneric conjugation. 30 Plasmid integration was confirmed by colony PCR using the primer pair 12 + 13 (Table 2 ) or primer 11 (Table 2) in combination with a reverse primer of corresponding gene.
pRM4vnlR Ab and pRM4vnlR Ab D51A were transferred into A. balhimycina through the direct transformation method 32,37 using unmethylated plasmid DNA isolated from E. coli ET12567. Integration of plasmid was verified by PCR using primer pair 11 + 3 ( Table 2 ). For deletion of vnlS Ab , A. balhimycina WT was transformed with pSPDvnlS Ab by direct transformation. The integration of the plasmid into the chromosome through homologous recombination was confirmed by PCR screening for the erythromycin resistance cassette, using primers ery for and ery rev (Table 2) . To obtain deletion mutants, a second homologous recombination event was provoked by stressing plasmid-carrying colonies as described by Puk et al. 38 Colonies were examined for sensitivity to erythromycin, and the deletions were verified by PCR analysis, using primers 16 + 17 ( Table 2) .
Sequence alignment
The amino acid (AA) sequences of VnlRS Ab Resistance test, reverse transcriptase polymerase chain reaction (RT-PCR) analyses, extraction of PG precursors, PG isolation, and the high-performance liquid chromatography-mass spectrometry (HPLC-MS) analyses were performed as described. 27, 40 Balhimycin concentration
The balhimycin concentration in 1 ml culture was quantified using HPLC with a photodiode array detector (HPLC-DAD) as described. 40 The balhimycin concentration was calculated to 100 mg/ml total DNA.
Inference of biomass concentration from DNA quantification
For the quantification of total DNA in 1 ml culture, an acid extraction of DNA coupled with a colorimetric method 41 was performed by measuring the absorbance at 600 nm. To analyze the amount of DNA, a standard curve with salmon sperm DNA was generated.
Results
A. balhimycina includes a VanRS homologous TCS (VnlRS Ab ) encoded in the balhimycin biosynthetic gene cluster
In most of the antibiotic-producing bacteria, the antibiotic biosynthetic gene clusters include resistance genes. One exception is the balhimycin producer A. balhimycina. In this study, the glycopeptide resistance genes vanHAX Ab are located 2 Mb apart from the balhimycin biosynthetic gene cluster. In addition, the resistance is characterized by another unusual feature: the counterpart of the well-known TCS VanRS, which is known to regulate vanHAX expression in pathogens and in S. coelicolor is encoded by genes (vnlRS Ab ), which are part of the biosynthetic gene cluster and are therefore not colocated with the vanHAX Ab genes.
VanRS Sc of S. coelicolor was reported to sense glycopeptides and to activate the expression of the vanHAX Sc genes. 19 To elucidate the differences of the two actinomycete TCSs, we compared the AA sequence of VnlRS Ab with the sequence of VanRS Sc . Sequence alignment using EMBOSS stretcher 39 revealed 82% sequence similarity between VnlR Ab and VanR Sc (Sco3590) and 73% between VnlS Ab and VanS Sc (Sco3589) (Fig. 1A, B) . Based on the high similarity, a corresponding function of both RRs could be proposed.
In S. coelicolor, VanS Sc phosphorylates VanR Sc at the aspartate at AA position 51. Replacement of this residue with an alanine completely destroyed the activity of VanR Sc . 6 It has been shown that in S. coelicolor, in the absence of vancomycin, acetylphosphate phosphorylates VanR Sc , whereas VanS Sc acts as a phosphatase to decrease the level of VanR Sc *P. On exposure to vancomycin, VanS activity switches from a phosphatase to a kinase and vancomycin resistance is induced. 6 Furthermore, Novotna et al. 42 specified a serine residue at AA position 69 important for autophosphorylation through acetyl phosphate.
Sequence comparison revealed that VnlR Ab contains both, a conserved aspartate at AA position 51 (D51) and a serine at AA position 69, the position that probably becomes autophosphorylated through acetyl phosphate (Fig. 1B) , indicating an analogous phosphorylation pattern of VnlR Ab compared with VanR Sc .
The RR VnlR Ab does not control expression of the vanHAX Ab genes in A. balhimycina
In A. balhimycina, vanHAX Ab expression does not depend on VnlRS Ab . The deletion of vnlR Ab had no effect on glycopeptide resistance and did not result in any obvious phenotype. 27 This raises the interesting question on the function of this TCS in A. balhimycina.
Since overexpression of RRs of two-component signal transduction systems often modulates multidrug resistance, 43 (Fig. 2) . All strains produced balhimycin at the same level ( Fig. 2A) . No differences in resistance against balhimycin were observed. Using a method optimized for actinomycetes, 27 muropeptides from all A. balhimycina strains cultivated under balhimycin production conditions were isolated. HPLC/MS chromatograms showed the similar muropeptide composition pattern for all strains (Fig. 2B) .
In addition to muropeptides, the PG precursors were analyzed. For this purpose, we cultivated the strains under balhimycin production conditions and conditions under which balhimycin production is disabled. Under production as well as under nonproduction conditions, A. balhimycina WT, A. balhimycina [vnlR Ab ], A. balhimycina DvnlR Ab , and A. balhimycina DvnlR Ab [vnlR Ab ] produced resistant PG precursors ending with d-Ala-d-Lac (Fig. 2C) (Fig. 2C) . These results suggest that VnlR Ab does not regulate the synthesis of resistance PG in A. balhimycina.
RT-PCR analyses revealed that a vanHAX Ab transcript was detectable in A. balhimycina DvnlR Ab , confirming that the expression of vanHAX Ab is independent of vnlR Ab (Fig. 3) . 6 to elucidate the ability of VnlR Ab to activate the vanHAX Sc genes in the S. coelicolor mutant. vnlRS Ab , vnlR Ab , and vnlS Ab were introduced into S. coelicolor DvanRS Sc under the control of the constitutive promoter ermEp* using the integrative plasmid pRM4vnlR Ab . The growth of the recombinant strains was tested on glycopeptide-containing plates.
Introduction of vnlRS Ab and of vnlR Ab alone into S. coelicolor M600 DvanRS Sc resulted in balhimycin-resistant strains (Fig. 4) . In contrast, expression of vnlS Ab alone did not change the glycopeptide-sensitive phenotype of the S. coelicolor DvanRS Sc mutant. These results indicated that VnlR Ab from A. balhimycina is able to activate the transcription of vanHAX Sc in S. coelicolor M600 also in the absence of VnlS Ab . Since in S. coelicolor M600 VanR Sc *P can be generated in a VanS Sc -independent manner using acetylphosphate, 6 we suggest a similar activation of VnlR Ab in the absence of VnlS Ab or VanS Sc .
The activation of the vanHAX Sc genes in the complemented S. coelicolor M600 DvanRS Sc mutant with vnlRS Ab and vnlR Ab was further analyzed by RT-PCR. For this purpose, RNA was isolated from 25-hr-old liquid cultures grown without addition of any glycopeptide. A vanHAX Sc transcript was detected when S. coelicolor M600 DvanRS Sc was complemented with vnlRS Ab or with vnlR Ab alone. However, in S. coelicolor M600 and in the S. coelicolor M600 DvanRS Sc mutant, transcription of the vanHAX Sc failed (Fig. 5) , confirming the functionality of VnlR Ab as transcriptional activator in S. coelicolor.
To investigate whether transcription of the vanHAX Sc genes indeed resulted in the formation of glycopeptideresistant PG precursors, which caused the resistant phenotype, we used HPLC/MS to analyze the PG precursor composition of S. coelicolor M600 DvanRS Sc and of S. coelicolor M600 DvanRS Sc complemented either with vnlRS Ab or vnlR Ab . Complementing S. coelicolor M600 DvanRS Sc with vnlRS Ab or with vnlR Ab restored the synthesis of resistant PG precursors. In the presence of balhimycin exclusively, PG precursors ending with d-Ala-d-Lac were synthesized (Fig. 6C,  D) . The PG precursor composition of the glycopeptidesensitive S. coelicolor M600 DvanRS Sc mutant was analyzed 
FIG. 5.
RT-PCR analyses of S. coelicolor M600 and different S. coelicolor M600 mutants. RNA was isolated after 25 hr of cultivation in the absence of any glycopeptide. hrdB: transcription of the housekeeping gene hrdB Sc . vanS Sc , vanR Sc , and vanHAX Sc : transcription of vanS Sc , vanR Sc , and vanHAX Sc . For PCR, genomic DNA (gDNA) was used as positive control.
after growing the strain in the absence of balhimycin. In this mutant, only sensitive cell wall precursors ending on d-Ala-dAla (1193 m/z) eluting at a retention time of 10-11 min were detected (Fig. 6A) .
The phosphorylation site D51 is essential for the function of VnlR Ab
To define the phosphorylation site of VnlR Ab , D51, which was identified as a likely phosphorylation site by sequence composition (Fig. 1) , was replaced by an alanine by exchanging nucleotide A to C at position 161 of vnlR Ab using the recombinant PCR method. The exchange was verified by sequence analysis. The mutated gene was cloned into the integrative vector pRM4 under the control of the ermEp* promoter and introduced into S. coelicolor M600 DvanRS Sc . The resulting recombinant strain was not able to grow in the presence of the tested glycopeptides (Fig. 4) . Therefore, we propose D51 as the VnlR Ab phosphorylation site.
VnlR Ab expands the glycopeptide resistance in S. coelicolor
The glycopeptide resistance mechanism in S. coelicolor belongs to the VanB type of resistance, meaning that glycopeptide resistance can only be induced by vancomycin or vancomycin-type glycopeptides, whereas teicoplanin (a type IV glycopeptide) fails to activate resistance, 42 resulting in a teicoplanin-sensitive phenotype of S. coelicolor. In contrast, A. balhimycina is resistant against vancomycin-as well as teicoplanin-type glycopeptides. To analyze whether the RR is responsible for determination of the glycopeptide resistance type, the recombinant strains S. ]) were able to grow also on teicoplanin-containing plates, whereas growth of S. coelicolor M600 WT was inhibited (Fig. 4) . These results indicated that VnlR Ab is able to induce teicoplanin resistance in S. coelicolor M600 by probably activating further genes required for teicoplanin resistance.
VnlR Ab influences antibiotic production in S. coelicolor
To analyze if the heterologous expression of VnlR Ab , in addition to the activation of the vanHAX Sc genes, causes further (morphological) changes in S. coelicolor M600, the growth and production of actinorhodin were investigated without the addition of any antibiotic. Similar titers of spores (1. (Fig. 4E) .
These results suggested that VnlR Ab is not only able to activate the vanHAX Sc genes in S. coelicolor M600 and to change its glycopeptide resistance type but it also has effects on other genes in S. coelicolor M600.
VnlR Ab is responsible for the activation of vanY Ab
Heterologous expression of VnlR Ab in S. coelicolor confirmed that it can take over the VanR Sc function to induce the expression of the vanHAX Ab genes and, in addition, can apparently induce the expression of further genes. In contrast, it is not involved in regulation of the vanHAX Ab genes in A. balhimycina. Since regulatory genes are often colocalized with its target genes, we speculated that VnlRS Ab might control vanY Ab , which is located directly adjacent to vnlR Ab and which encodes a carboxypeptidase. Previous studies showed that VanY Ab cleaves the d-Ala-d-Ala dipeptide from the PG precursors, but it is not able to cleave the d-Ala-dLac depsipeptide. 27 To investigate, whether VnlR Ab regulates the expression of vanY Ab , transcriptional analyses were performed. RT-PCR analyses revealed that vanY Ab was only transcribed when vnlR Ab was expressed under the control of the strong promoter ermE*p (Fig. 2 (A. balhimycina [vnlR Ab ]). In A. balhimycina WT, transcription was detectable on a low level only after 63 hr of cultivation and in the A. balhimycina DvnlR Ab mutant, vanY Ab transcription was not induced at all (Fig. 2) . This result was confirmed by RNA-seq analyses where we compared the transcription level of vanY Ab in the A. balhimycina WT and A. balhimycina DvnlR Ab (data not shown). The transcription of vanY Ab was 25-fold decreased in A. balhimycina DvnlR Ab compared with A. balhimycina WT. We therefore concluded that the RR VnlR Ab in A. balhimycina is involved in controlling the expression of resistance mediated by VanY Ab .
Discussion
Glycopeptide resistance in pathogens and in S. coelicolor is mediated by the action of VanHAX. The expression of the vanHAX genes is regulated by the TCS VanRS, the genes of which are colocalized with vanHAX. In the presence of glycopeptides, VanS becomes autophosphorylated A. balhimycina produces the vancomycin-like glycopeptide balhimycin and has to protect itself from the action of the glycopeptide. 45 The genome of A. balhimycina includes vanHAX Ab genes and vanRS-like genes (vnlRS Ab ). However, in contrast to other glycopeptide-resistant bacteria, the vanHAX Ab genes in A. balhimycina are located 2 Mb apart from the vnlRS Ab genes, which are part of the balhimycin biosynthetic gene cluster. 40 RT-PCR experiments revealed that VnlR Ab is not involved in the activation of the vanHAX Ab genes in A. balhimycina. Subsequent PG analyses confirmed that a vnlR Ab deletion mutant cannot synthesize resistant muropeptides. Since vnlR Ab is colocalized with the balhimycin biosynthetic genes, an alternative role of VnlR Ab as regulator of balhimycin synthesis was assumed, but the deletion of the vnlR Ab did not affect balhimycin production. Hence, VnlR Ab is not the central regulator activating the vanHAX Ab resistance genes or the balhimycin biosynthetic genes.
To further investigate the potential target gene(s) of VnlR Ab , we analyzed the transcription of vanY Ab , which encodes a carboxypeptidase and which is located adjacent to the vnlRS Ab genes in the balhimycin biosynthetic gene cluster. 25 RT-PCR and RNA-seq analyses revealed that vanY Ab expression was 25-fold decreased in A. balhimycina DvnlR Ab compared with A. balhimycina WT.
VanY Ab is a d,d-carboxypeptidase, which cleaves the endstanding d-Ala from lipid II, resulting in the formation of tetrapeptides. 27 In contrast to other described carboxypeptidases, 46 VanY Ab has no d,d-carboxyesterase activity. The tetrapeptides are the substrates for the l,d-transpeptidase (Ldt), which subsequently cross-links the tetrapeptide acyl donors at the third AA. This results in PG with 3-3 crosslinked tetra-and tripeptides, which are devoid of the d-Ala-dAla-ending peptides, and which can therefore not serve as target of glycopeptides anymore. 47 Investigations of the PG of A. balhimycina revealed the presence of 3-3 cross-linked tetra-and tripeptides. 40, 45 Furthermore, we could identify at least three ldt genes in the genome of A. balhimycina. 45 We therefore speculate that by activating the expression of vanY Ab , VnlR Ab is involved in regulating an alternative, VanHAX Ab -independent glycopeptide resistance mechanism in A. balhimycina. This fact is further confirmed by RT-PCR analysis, where it was shown that VanY Ab is expressed in A. balhimycina DvanHAX Ab . 40 This observation is in accordance with the findings in Nonomuraea ATCC 39727, the producer of the dalbavancin precursor A40926. Nonomuraea ATCC 39727 does not encode VanHAX homologs, but possesses a VanY homolog (VanY n ) for the synthesis of a resistant PG precursor. 48 As described for A. balhimycina, VanY n cleaves the C-terminal d-Ala from the pentapeptide as well as from the d-Ala-d-Ala dipeptide. The tetrapeptides are subsequently cross-linked by Ldt, resulting in glycopeptide-resistant cell wall. 47 The surprising features of VnlR Ab are that although it does not regulate the transcription of the vanHAX Ab genes in A. balhimycina, it is able to activate vanHAX Sc transcription in S. coelicolor, and that it activates teicoplanin resistance in S. coelicolor.
Activation of the vanHAX Sc transcription can be explained by the binding of VnlR Ab at the promoter region of vanHAX Sc . Sequence comparison of the promoter regions of vanHAX Sc and vanHAX Ab not only revealed conserved motives but also some differences (data not shown). Although many attempts have been made to analyze putative promoter sequences in gel mobility assays, no shifts could be observed. This is probably due to the fact that after purification, the protein lost its functionality (data not shown). Therefore, determination of the exact binding motive of VnlR Ab still requires alternative approaches.
VnlR Ab was not only able to restore vancomycin resistance in an S. coelicolor DvanRS Ab mutant after heterologous expression but it even conferred teicoplanin resistance to this mutant, although S. coelicolor WT is sensitive toward teicoplanin. Recent comparative study of the VanR-VanS systems from two Streptomyces strains, S. coelicolor and Streptomyces toyocaensis (the producer of the sugarless glycopeptide A47934), indicated that the glycopeptide antibiotic inducer specificity is determined solely by the differences between the AA sequences of the VanRVanS TCS present in each strain rather than by any inherent differences in general cell properties, including cell wall structure and biosynthesis. 42 On the one hand, the results obtained in this work support this finding; since vnlR Ab is under the control of the ermEp* promoter, VnlR Ab is constitutively expressed and activates the transcription of the vanHAXJK Sc genes in S. coelicolor independent from the presence of any glycopeptide. The activation of van-HAXJK Sc resulted in the synthesis of PG with pentapeptides ending on d-Ala-d-Lac depsipeptide, which are resistant against vancomycin and teicoplanin. On the other hand, the second explanation contradicts the work of Novotna et al.
42
; it is likely that VnlR Ab activates the transcription of additional unknown genes, which mediate teicoplanin resistance.
The diverse functionality of VnlR Ab in the glycopeptide producer A. balhimycina and in the nonproducer S. coelicolor provides the starting point of evolutionary analyses of glycopeptide resistance. In pathogenic bacteria and in S. coelicolor of glycopeptides, resistance is strictly regulated and is induced by the presence of glycopeptides. In contrast, glycopeptide producers overcome this regulation not only by the constitutive expression of the vanHAX genes but also by the development of a vanHAX-independent resistance mechanism. However, the ability of VnlR Ab to activate transcription of vanHAX in S. coelicolor is an indication of a common origin of the three glycopeptide resistance mechanisms, the inducible one, the constitutively expressed, and the vanHAX-independent mechanism. Whether and how the complex resistance mechanism has evolved in the glycopeptide producers and whether and how it was transferred into resistance pathogens have to be subjects of future investigation.
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